Tattoo-associated uveitis was once considered rare; however, that appears to be no longer true, according to a new Australian ...

(Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced the first patient dosed in ...